4.6 Article

The Role of the HIF-1α Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions

Journal

PLOS ONE
Volume 9, Issue 5, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0097938

Keywords

-

Funding

  1. MRC
  2. CONACYT [200721]
  3. Stockholm County Council
  4. Karolinska Institutet
  5. CRUK
  6. Cancer Research UK [19276] Funding Source: researchfish

Ask authors/readers for more resources

HIF-1 is a transcription factor that mediates the cellular responses to low oxygen environments, mainly as a result of having an oxygen-labile subunit, HIF-1 alpha. HIF-1 alpha has been carefully studied in the context of severe hypoxic stresses (<1% O-2), but it is also known to be present at oxygen tensions commonly found in normal tissues in vivo (similar to 1-13% O-2), albeit at much lower levels. Its role under these physiological conditions is not fully understood. Here, we show that a transcriptionally active HIF-1 alpha was up-regulated at 5% O-2, both in normal and cancer cells, but only some of its target genes were elevated as a result. HIF-1 alpha induction was in part dependent on the activation of the ERK1/2 MAPK signalling pathway, which we have previously shown is active at 5% O-2. We also found that HIF-1 alpha does not contribute to the protection against DNA damage that can be observed in low oxygen environments, and that there are certain DNA damaging agents, such as doxorubicin and actinomycin D, that prevent HIF-1 alpha induction independently of p53. Moreover, absence of HIF-1 alpha significantly reduced the growth advantage of cells cultured at 5% O-2. In view of these data, we conclude that HIF-1 alpha can be induced and activated at physiological oxygen tensions in a MAPK-dependent manner and that, although this does not lead to pro-survival responses to stress, it determines the increased cell proliferation rates that are common under these conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

PML-II regulates ERK and AKT signal activation and IFNα-induced cell death

Xueqiong Meng, Yixiang Chen, Salvador Macip, Keith Leppard

Summary: Depletion of PML-II in HeLa cells reduced cell death induced by IFN alpha, decreased expression of pro-apoptotic ISG proteins, and suppressed expression of PUMA and TRAIL. Lack of PML-II also enhanced pro-survival signaling activation, leading to increased resistance to IFN alpha-induced apoptosis.

CELL COMMUNICATION AND SIGNALING (2021)

Article Biochemistry & Molecular Biology

Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity

Samuel B. Bader, Tiffany S. Ma, Charlotte J. Simpson, Jiachen Liang, Sakura Eri B. Maezono, Monica M. Olcina, Francesca M. Buffa, Ester M. Hammond

Summary: This study demonstrates that fluctuating hypoxic conditions inducing replication catastrophe lead to increased expression and activity of APOBEC3B, contributing to the accumulation of APOBEC-mediated mutations. In contrast, stable hypoxic conditions do not significantly impact APOBEC3B. The number of APOBEC-mediated mutations in patient tumors is closely correlated with a hypoxia signature, indicating that hypoxia-induced replication catastrophe drives genomic instability in tumors through increasing the activity of APOBEC3B.

NUCLEIC ACIDS RESEARCH (2021)

Editorial Material Oncology

Elucidating the role of transiently hypoxic tumour cells on radiation resistance

Geoff S. Higgins, Ester M. Hammond

Summary: The study investigates the contribution of acute/transient hypoxia and chronic hypoxia to radiosensitivity, using two hypoxia markers and pentoxifylline to enhance blood flow to regions experiencing transient hypoxia.

BRITISH JOURNAL OF CANCER (2022)

Article Chemistry, Multidisciplinary

Snapshot imprinting: rapid identification of cancer cell surface proteins and epitopes using molecularly imprinted polymers

Stanislav S. Piletsky, Elena Piletska, Marta Poblocka, Salvador Macip, Donald J. L. Jones, Marta Braga, Thong H. Cao, Rajinder Singh, Alan C. Spivey, Eric O. Aboagye, Sergey A. Piletsky

Summary: Proteomic mapping of cell surfaces is crucial for drug development and clinical diagnostics. The 'snapshot imprinting' method described in this work enables the identification of cell surface markers and epitopes, with potential applications in personalized cancer treatment. The analysis of cancer cell lines and selective targeting of specific epitopes using molecularly imprinted polymer nanoparticles demonstrate the effectiveness of this approach.

NANO TODAY (2021)

Article Oncology

poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells

Xueqiong Meng, Xiaoxi Cui, Xiaoya Shao, Yanqi Liu, Yihao Xing, Victoria Smith, Shiqiu Xiong, Salvador Macip, Yixiang Chen

Summary: The combination of dsRNA poly(I:C) and proteasome inhibitors synergistically induce apoptosis in cervical cancer cells by activating multiple pro-apoptotic pathways, suggesting a potential therapeutic combination.

TRANSLATIONAL ONCOLOGY (2022)

Review Oncology

At the Crossroads of Life and Death: The Proteins That Influence Cell Fate Decisions

Vinesh Dhokia, John A. Y. Moss, Salvador Macip, Joanna L. Fox

Summary: Cellular senescence and apoptosis were historically considered as distinct cell fate pathways, but they share common proteins. p53 plays a key role in determining cell fate, but its decision-making process is not fully understood. Cell fate is dynamic and can be shifted by the right combination of activators and inhibitors. This review focuses on the regulation and induction of apoptosis and senescence, as well as their alterations in chronic diseases.

CANCERS (2022)

Review Public, Environmental & Occupational Health

Individual Freedom in the Initial Response to Covid-19

Salvador Macip, Oriol Yuguero

Summary: COVID-19 pandemic poses significant challenges to global healthcare and exacerbates social issues and inequalities. This generates a series of ethical problems that require careful analysis to avoid repeating similar mistakes in future crises.

FRONTIERS IN PUBLIC HEALTH (2022)

Article Oncology

IFN-γ enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway

Xiaoya Shao, Xueqiong Meng, Haiping Yang, Xinxin Wang, Ling Qin, Guomin Shen, Xiaoping Xi, Huijuan Zhao, Salvador Macip, Yixiang Chen

Summary: In this study, we found that IFN-gamma secreted by dysfunctional T cells can enhance CLL cells resistance to ABT-199. The expression of anti-apoptotic proteins BCL-2, MCL-1, and BCL-xL were up-regulated by IFN-gamma stimulation via JAK1/2-STAT3 pathway. Blocking this pathway with inhibitors increased the efficiency of ABT-199 to induce CLL cell apoptosis, suggesting a potential therapeutic combination strategy to overcome ABT-199 resistance.

LEUKEMIA & LYMPHOMA (2023)

Article Oncology

How the histological structure of some lung cancers shaped almost 70 years of radiobiology

Katja R. Worth, Ioanna Papandreou, Ester M. Hammond

Summary: Louis Harold Gray's pivotal research in the 1950s demonstrated the vital role of oxygen in radiotherapy. This research inspired further studies into the mechanistic role of molecular oxygen and its relationship with tumor hypoxia and patient outcomes. Despite the abundance of pre-clinical data supporting hypoxia-targeted treatments, the clinical application of these therapies remains limited.

BRITISH JOURNAL OF CANCER (2023)

Article Chemistry, Multidisciplinary

Two Color Imaging of Different Hypoxia Levels in Cancer Cells

Antoine L. D. Wallabregue, Hannah Bolland, Stephen Faulkner, Ester M. Hammond, Stuart J. Conway

Summary: Hypoxia, which occurs in various biological contexts, has a negative impact on the survival of biological systems such as plants, bacterial biofilms, and tumors. Chemical probes that can study biological hypoxia help to improve the understanding and treatment of diseases related to low oxygen levels. This study presents a range of indolequinone-based bioreductive fluorescent probes that can image different levels of hypoxia in cellular cultures, providing a convenient alternative to antibody-based imaging approaches.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Chemistry, Multidisciplinary

Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells

Marie H. C. Boulet, Hannah R. Bolland, Ester M. Hammond, Adam C. Sedgwick

Summary: Platinum (IV) anticancer agents show potential to overcome limitations of commonly used Pt (II) chemotherapeutics and an improved understanding of their intracellular reduction is needed. Two fluorescence responsive oxaliplatin (IV) complexes, OxaliRes and OxaliNap, were synthesized and showed increased fluorescence emission intensity upon reduction by sodium ascorbate (NaAsc). Treatment with NaAsc increased fluorescence intensity in a dose-dependent manner in colorectal cancer cells. Hypoxia-induced reduction of OxPt (IV) complexes with <0.1% O-2 resulted in the greatest fluorescence signal and showed significant differences in toxicity compared to normoxia (21% O-2).

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Oncology

Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation

Katarzyna B. Leszczynska, Monika Dzwigonska, Hala Estephan, Jutta Moehlenbrink, Elizabeth Bowler, Amato J. Giaccia, Jakub Mieczkowski, Bozena Kaminska, Ester M. Hammond

Summary: Local hypoxia in solid tumors is associated with aggressive disease and therapy resistance. Widespread changes in gene expression occur in response to hypoxia, with decreased chromatin accessibility and specific pathways affected. The RNA helicase DDX5 is repressed in hypoxia and its rescue further accumulates replication stress and R-loop levels. These findings suggest that the repression of multiple R-loop processing factors, including DDX5, is a critical part of the biological response to hypoxia.

MOLECULAR ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Hypoxia-induced transcriptional stress is mediated by ROS-induced R-loops

Tiffany S. Ma, Katja R. Worth, Conor Maher, Natalie Ng, Chiara Beghe, Natalia Gromak, Anna M. Rose, Ester M. Hammond

Summary: Hypoxia, a common feature of solid tumors, can lead to the accumulation of R-loops, which affects gene transcription and ribosomal RNA synthesis, playing a critical role in tumorigenesis.

NUCLEIC ACIDS RESEARCH (2023)

Article Chemistry, Multidisciplinary

Antibody-Based Imaging of Bioreductive Prodrug Release in Hypoxia

Cagla Tosun, Antoine L. D. Wallabregue, Maxim Mallerman, Sarah E. Phillips, Claire M. Edwards, Stuart J. Conway, Ester M. Hammond

Summary: Hypoxia-activated prodrugs (HAPs) are a promising strategy for targeting hypoxic regions in tumors while sparing normal tissue. However, visualizing the delivery and activation of HAPs in hypoxic regions has been a challenge. In this study, a modified version of a nitroimidazole bioreductive group was developed to enable imaging of the release of a fluorescent dye and the activation of the prodrug using the EF5 antibody. This modified bioreductive group was used to synthesize a new prodrug, EF5-Pano, which showed imaging capability and cytotoxic effects in hypoxic multiple myeloma cells.

JACS AU (2023)

Article Chemistry, Multidisciplinary

Molecular imprinting as a tool for determining molecular markers: a lung cancer case

Elena Piletska, Kirabo Magumba, Lesslly Joseph, Alvaro Garcia Cruz, Rachel Norman, Rajinder Singh, Antonella F. S. Tabasso, Donald J. L. Jones, Salvador Macip, Sergey Piletsky

Summary: Determining the sensitivity of lung cancer cell lines to ionising radiation based on cell surface proteomic differences was achieved using molecular imprinting technology. The analysis identified two membrane proteins associated with radiotherapy resistance, indicating the potential of this technology in discovering new biomarkers and developing personalized medicine approaches for cancer treatment.

RSC ADVANCES (2022)

No Data Available